Haisco Pharmaceutical Group company profile

002653 · SZSE · CNY

Compare Haisco Pharmaceutical Group
¥52.48Change from previous close: −2.13%Absolute change: −¥1.14

Close · November 20, 2026

Company profile

Haisco Pharmaceutical Group has 5,597 employees and is headquartered in Shannan, China.

China is the main market for Haisco Pharmaceutical Group Co., Ltd., which researches, develops, manufactures and sells pharmaceutical products there. Its portfolio covers anesthesia and analgesic drugs, endocrine system treatments, enteral and parenteral nutrition products, cardiovascular, psychiatric, tumor-related and digestive liver disease medicines, and treatments for other diseases. The group also works with Eli Lilly on medicines spanning several therapeutic fields, and it changed its name from Xizang Haisco Pharmaceutical Group in March 2016.

In the fiscal year ended December 2025, the company reported revenue of CNY 4.4 billion, up 17.9% from the previous year, and net profit of CNY 259.6 million. It employs 5,597 people and is headquartered in Shannan, China, where it was founded in 2000.

Company facts

Industry
Biotechnology
Country
China
Headquarters
No. 17 Sanxiang Avenue, 856000, Shannan
Employees
5,597
Chief executive
Pangke Yan
Founded
2000
Fiscal year
January - December
Listing
002653 · SZSE
Currency
CNY
ISIN
CNE100001BC7
Website
haisco.com

Haisco Pharmaceutical Group and its competitors

The most similar companies by business and size

CompanyCountryMarket capEmployeesOperating marginP/E (trailing 12 months)
Haisco Pharmaceutical Group002653China$8.97B5,59721.1%44.1
ALTEOGEN196170South Korea$9.05B18147.2%97.1
Genscript Biotech1548Hong Kong SAR China$8.77B6,13514.9%—
Pharmaron Beijing300759China$10.59B25,08814.0%39.3
Sino Biopharmaceutical1177Hong Kong SAR China$11.65B22,83828.2%34.2
Akeso9926Hong Kong SAR China$6.81B4,082-30.7%—

Competitors: same or related industry, same region first, then the closest market capitalization. Market cap converted into US dollars at the latest exchange rates; P/E over the last 12 months, not shown when negative.

Compare Haisco Pharmaceutical Group with its competitors